Spots Global Cancer Trial Database for potential predictors
Every month we try and update this database with for potential predictors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma | NCT06344299 | Pancreatic Duct... | potential predi... | 75 Years - 100 Years | Fudan University | |
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | NCT02978443 | Acral Lentigino... Mucosal Melanom... | Nivolumab Ipilimumab | 18 Years - | Georgetown University | |
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | NCT02978443 | Acral Lentigino... Mucosal Melanom... | Nivolumab Ipilimumab | 18 Years - | Georgetown University | |
Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma | NCT06344299 | Pancreatic Duct... | potential predi... | 75 Years - 100 Years | Fudan University |